Riskpilot← Back to searchSign inGet full accessP. Olander Medica development AB
ABActiveOrg 5592354301Sparsörsvägen 1Research and experimental development on natural sciences and engineering · NACE 7210Est. 20200 employees
Revenue 2025
—
EBITDA margin
—
-783% vs 2024
Equity ratio
15.1%
Financial strength
Net profit 2025
SEK -28K
-456% vs 2024
| Revenue | — | — |
| EBITDA | SEK -441K | -783% |
| Net profit | SEK -28K | -456% |
| Total assets | SEK 34M | +56% |
| Equity | SEK 5,1M | +11534% |
| Employees | 0 | — |
Legal name
P. Olander Medica development AB
Org number
5592354301
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
7 januari 2020
Share capital
SEK 51 168
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva forskning, utveckling och försäljning av medicinsk utrustning samt därmed förenlig verksamhet.
Address
Sparsörsvägen 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | — |
| Staff expenses | — | — | — | — | — |
| EBITDA | −453 | −168 | −189 | −50 | −441 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | — |
| EBIT | −453 | −168 | −189 | −50 | −441 |
| Net financials | — | — | — | — | −16 |
| Profit before tax | 0 | 0 | 0 | 1 | −28 |
| Tax | −0 | −0 | −0 | −6 | — |
| Net profit | 0 | 0 | 0 | −5 | −28 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 8 388 | 10 087 | 15 218 | 21 739 | 33 969 |
| Equity | 49 | 49 | 49 | 44 | 5 119 |
| Long-term debt | 7 085 | 9 410 | 14 055 | 20 681 | 23 571 |
| Short-term debt | 1 254 | 627 | 1 114 | 1 014 | 5 279 |
| Total debt | 8 339 | 10 037 | 15 169 | 21 695 | 28 850 |
EBITDA margin
-44137000.0%
This company
15.8%
Market median
-279348201% vs market
20212025
Equity ratio
15.1%
This company
38.2%
Market median
-60% vs market
20212025
Return on equity
-0.5%
This company
18.4%
Market median
-103% vs market
20212025
Net profit margin
-2778700.0%
This company
8.1%
Market median
-34305038% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
5.64×
This company
0.62×
Market median
-810% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PM Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Former (4) | ||
| Chairman | 2020 – 2022 | |
| Board of Directors | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
P. Olander Medica Intressenter AB
P. Olander Medica development AB Board members of P. Olander Medica development AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Magnus Olander | Chief Executive Officer | 0 companies |
| M H Charlotte Wiberg Larsson | Chairman | 0 companies |
| Bo Torsten Nilsson | Board of Directors | 0 companies |
| Peter Jonas Michael Carlborg | Deputy Board Member | 0 companies |
| Johan Per Lars Olander | Deputy Board Member | 0 companies |
| Bo Torsten Patrik Nilsson | Deputy Board Member | 0 companies |